Skip to main content
Equibles
BLCO logo

BLCO · Bausch & Lomb Corp · Metrics

Track BLCO — free

Use BLCO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BLCO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$17.25 -0.30 (-1.71%) At close · Sep 11
Rebalance outlook locked
Market Cap
$6.16B
Shares
357.17M

BLCO metrics

79 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$17.25
Market cap
$6.16B

Price action

20 metrics
Price change (1W)
-3.3%
Price change (30D)
+3.4%
Price change (3M)
+14.8%
Price change (6M)
+5.9%
Price change (YTD)
+2.8%
Price change (1Y)
+17.0%
Trailing year
Price change (5Y)
—
52-week high
$18.60
52-week low
$14.32
Change from 52-week high
-5.6%
Change from 52-week low
+22.6%
Annualized volatility
29.3%
Annualized volatility (3M)
25.6%
Beta
1.0
RSI (14D)
55.3
Price vs SMA 50
+3.9%
Price vs SMA 200
+5.8%
Avg volume (3M)
408,424
Relative volume
1.3
Average dollar volume
$6.79M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
357.17M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.0×
reciprocal yield 49.0%
EV / EBITDA
14.8×
reciprocal yield 6.8%
EV / EBIT
33.7×
reciprocal yield 3.0%
P / sales
1.2×
reciprocal yield 86.4%
P / book
1.0
reciprocal yield 103.5%
FCF yield
2.2%
TTM · current market cap
Buyback yield
—
P / FCF
45.0
reciprocal yield 2.2%
P / operating cash flow
13.5
reciprocal yield 7.4%
Earnings yield
-2.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.2×
reciprocal yield 46.4%
EV / revenue historical average (5Y)
2.2×
reciprocal yield 46.2%
EV / EBIT historical average (3Y)
92.1×
reciprocal yield 1.1%
EV / EBIT historical average (5Y)
86.2×
reciprocal yield 1.2%
EV / EBITDA historical average (3Y)
18.1×
reciprocal yield 5.5%
EV / EBITDA historical average (5Y)
17.9×
reciprocal yield 5.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
—
Operating margin
6.1%
Trailing 12 months
Net margin
-3.2%
Gross profit (TTM)
—
Operating profit (TTM)
$323.00M
Net income (TTM)
−$171.00M
Trailing 12 months
Diluted EPS (TTM)
$-0.48
FCF margin
2.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$18.20

Growth

11 metrics
Revenue growth YoY
+9.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$5.32B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.0%
Year over year · more shares
Revenue CAGR (3Y)
+10.6%
Revenue CAGR (5Y)
+8.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-2.7%
Return on assets
-1.2%
Debt / equity
0.8
Current ratio
1.5
EBITDA (TTM)
$734.00M
Free cash flow (TTM)
$137.00M
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
6.4
Return on invested capital
—
Trailing 12 months
Net cash
−$4.71B
Latest balance sheet
Cash & equivalents
$367.00M
Total assets
$13.86B
Total debt
$5.08B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$458.00M
Capital expenditures (TTM)
$321.00M
R&D (TTM)
$404.00M
SG&A (TTM)
$2.22B
Stock compensation (TTM)
$163.00M
R&D / revenue
7.6%
Stock compensation / revenue
3.1%

Ownership (13F)

3 metrics
13F filers
98
13F filer change QoQ
+2
Institutional ownership
10.8%

Short interest

3 metrics
Short interest
1.0%
Latest settlement · 7.9 days to cover
Days to cover
7.9d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.19M
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1860742 CUSIP 071705107 13F (30d) 60 filings 60 filers Visit website Investor relations